@Biotech777 @affimed @pilarnavaparada $AFMD AFM24 gains on engagement of the adaptive immune system via T-cell infiltration are promising for the #atezolizumab (anti-PDL1) combo trial and should be exploited with a new combo of one of Affimed own EGFR / #C
3,931 followers
253 followers
@Long6422Da @dhovekamp42 @biosleuth 1 was the older NK version, and, one, if memory is correct, was a T-cell bispecific targeting EGFR. Differences I believe involved potency and, more important, half life. T-cell research outlined here: https://t.co/VIoQd
2,388 followers
RT @deCustine: Scaling issues for $KITE + $NVS CD19 CAR-T therapies potentially ameliorated with $AFMD "off-the-shelf" TandAbs https://t.co…
3,931 followers
@PjornP You find some $AFMD #AFM24 EGFR preclinical data here EACR-AACR-SIC 2017 https://t.co/fa9zblNrKO here publication https://t.co/yZEMEkWpL4 and AACR 2017 https://t.co/UefB4JpH8H